New answer by Medical Oncologist at University of Texas MD Anderson Cancer Center (February 20, 2017)
The answer to this question has not been well studied, but the registration trials that led to the approval of T-DM1 (EMILIA and TH3RESA) did not use T-DM1 with concurrent hor...